Blue Jet Healthcare [BLUEJET] vs Supriya Lifescience [SUPRIYA] Detailed Stock Comparison

Blue Jet Healthcare Ltd.

NSE
Loading...

Supriya Lifescience Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Blue Jet Healthcare Ltd. wins in 8 metrics, Supriya Lifescience Ltd. wins in 12 metrics, with 0 ties. Supriya Lifescience Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Blue Jet Healthcare Ltd. Supriya Lifescience Ltd. Better
P/E Ratio (TTM) 23.87 27.94 Blue Jet Healthcare Ltd.
Price-to-Book Ratio 5.56 4.78 Supriya Lifescience Ltd.
Debt-to-Equity Ratio 1.64 0.48 Supriya Lifescience Ltd.
PEG Ratio -0.77 4.65 Supriya Lifescience Ltd.
EV/EBITDA 18.91 19.44 Blue Jet Healthcare Ltd.
Profit Margin (TTM) 27.88% 25.19% Blue Jet Healthcare Ltd.
Operating Margin (TTM) 21.26% 31.61% Supriya Lifescience Ltd.
EBITDA Margin (TTM) 21.26% 31.61% Supriya Lifescience Ltd.
Return on Equity 26.93% 18.86% Blue Jet Healthcare Ltd.
Return on Assets (TTM) 21.53% 16.90% Blue Jet Healthcare Ltd.
Free Cash Flow (TTM) $-341.15M $22.99M Supriya Lifescience Ltd.
Dividend Yield 0.22% 0.27% Supriya Lifescience Ltd.
1-Year Return -46.26% 41.71% Supriya Lifescience Ltd.
Price-to-Sales Ratio (TTM) 6.64 7.03 Blue Jet Healthcare Ltd.
Enterprise Value $65.92B $50.78B Blue Jet Healthcare Ltd.
EV/Revenue Ratio 6.26 6.90 Blue Jet Healthcare Ltd.
Gross Profit Margin (TTM) 51.75% 70.35% Supriya Lifescience Ltd.
Revenue per Share (TTM) $61 $91 Supriya Lifescience Ltd.
Earnings per Share (Diluted) $16.90 $23.01 Supriya Lifescience Ltd.
Beta (Stock Volatility) 0.37 0.28 Supriya Lifescience Ltd.

Blue Jet Healthcare Ltd. vs Supriya Lifescience Ltd. Stock Performance Analysis

Loading Price Chart...

BLUEJET
SUPRIYA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Blue Jet Healthcare Ltd.-1.60%11.86%17.17%41.50%-8.00%-4.67%
Supriya Lifescience Ltd.-2.25%3.93%38.73%66.47%32.20%28.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Blue Jet Healthcare Ltd.-46.26%31.46%31.46%31.46%31.46%31.46%
Supriya Lifescience Ltd.41.71%283.42%102.02%102.02%102.02%102.02%

Performance & Financial Health Analysis: Blue Jet Healthcare Ltd. vs Supriya Lifescience Ltd.

MetricBLUEJETSUPRIYA
Market Information
Market Cap i₹69.97B₹51.74B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i473,848200,097
90 Day Avg. Volume i572,203176,231
Last Close₹504.30₹955.20
52 Week Range₹325.00 - ₹1,027.80₹545.50 - ₹1,085.00
% from 52W High-50.93%-11.96%
All-Time High₹1,027.80 (Jul 21, 2025)₹1,085.00 (Jun 01, 2026)
% from All-Time High-50.93%-11.96%
Growth Metrics
Quarterly Revenue Growth-0.40%0.11%
Quarterly Earnings Growth-0.59%0.06%
Financial Health
Profit Margin (TTM) i0.28%0.25%
Operating Margin (TTM) i0.21%0.32%
Return on Equity (TTM) i0.27%0.19%
Debt to Equity (MRQ) i1.640.48
Cash & Liquidity
Book Value per Share (MRQ)₹72.50₹134.51
Cash per Share (MRQ)₹23.76₹12.82
Operating Cash Flow (TTM) i₹899.31M₹1.87B
Levered Free Cash Flow (TTM) i₹3.05B₹1.88B
Dividends
Last 12-Month Dividend Yield i0.22%0.27%
Last 12-Month Dividend i₹1.20₹1.80

Valuation & Enterprise Metrics Analysis: Blue Jet Healthcare Ltd. vs Supriya Lifescience Ltd.

MetricBLUEJET (Apr 26, 2026)SUPRIYA (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i23.8727.94
Forward P/E i22.7020.97
PEG Ratio i-0.774.65
Price to Sales (TTM) i6.647.03
Price to Book (MRQ) i5.564.78
Market Capitalization
Market Capitalization i₹69.97B₹51.74B
Enterprise Value i₹65.92B₹50.78B
Enterprise Value Metrics
Enterprise to Revenue i6.266.90
Enterprise to EBITDA i18.9119.44
Risk & Other Metrics
Beta i0.370.28
Book Value per Share (MRQ) i₹72.50₹134.51

Financial Statements Comparison: Blue Jet Healthcare Ltd. vs Supriya Lifescience Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBLUEJET (2025)SUPRIYA (2025)
Revenue/Sales i10.26B6.80B
Cost of Goods Sold i4.70B2.86B
COGS % of Revenue i45.8%42.1%
Gross Profit i5.56B3.93B
Gross Margin i54.2%57.9%
Research & Development i15.52MN/A
Operating Income (EBIT) i3.60B2.36B
Operating Margin i35.1%34.7%
EBITDA i4.05B2.66B
EBITDA Margin i39.5%39.2%
Pre-Tax Income i4.06B2.48B
Pre-Tax Income % of Revenue i39.6%36.6%
Income Tax i1.01B605.23M
Income Tax % of Revenue i9.8%8.9%
Net Income (Profit) i3.05B1.88B
Profit Margin i29.7%27.7%

Balance Sheet & Liquidity Metrics

MetricBLUEJET (2025)SUPRIYA (2025)
Cash & Equivalents i329.79M759.97M
Total Current Assets i10.06B4.37B
Total Current Assets % of Revenue i98.0%64.3%
Total Current Liabilities i2.56B821.62M
Total Current Liabilities % of Revenue i24.9%12.1%
Long-Term Debt i165.26M50.57M
Long-Term Debt % of Revenue i1.6%0.7%
Total Shareholders Equity i11.33B9.97B
Retained Earnings i10.98B7.82B
Retained Earnings % of Revenue i107.0%115.1%
Property, Plant & Equipment i212.65M645.91M

Cash Flow Statement Comparison

MetricBLUEJET (2025)SUPRIYA (2025)
Operating Cash Flow i899.31M1.87B
Operating Cash Flow % of Revenue i8.8%27.6%
Capital Expenditures i-794.98M-1.62B
Free Cash Flow i-341.15M22.99M
FCF Margin i-3.3%0.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBLUEJETSUPRIYA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i173.47M80.48M
Float Shares i33.13M25.52M
% Held by Insiders i79.81%70.84%
% Held by Institutions i1.90%4.42%
% Held by Public i18.29%24.74%

Dividend Analysis & Yield Comparison: Blue Jet Healthcare Ltd. vs Supriya Lifescience Ltd.

MetricBLUEJETSUPRIYA
Last 12-Month Dividend i₹1.20₹1.80
Last 12-Month Dividend Yield i0.22%0.27%
3-Year Avg Annual Dividend i₹0.73₹0.80
3-Year Avg Dividend Yield i0.19%0.17%
3-Year Total Dividends i₹2.20₹2.40
Ex-Dividend DateSep 19, 2025Sep 04, 2025